Covered recipient · General Payments record
CHRISTINA M KAMINSKYJ
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2024
$479.98
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $479.98 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Madrigal Pharmaceuticals | $159.52 | 2 |
| Lilly USA, LLC | $120.29 | 1 |
| PFIZER INC. | $113.59 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.85 | 1 |
| ARGENX US, INC. | $17.16 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.05 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $16.97 | 1 |
| Merck Sharp & Dohme Corporation | $15.55 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $479.98 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $17.05 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000587 | CMS |
| ARGENX US, INC. | $17.16 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142151508 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.85 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086310689 | CMS |
| Intercept Pharmaceuticals, Inc. | $16.97 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113647079 | CMS |
| Lilly USA, LLC | $120.29 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135600519 | CMS |
| Madrigal Pharmaceuticals | $44.36 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144193445 | CMS |
| Madrigal Pharmaceuticals | $115.16 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144193447 | CMS |
| Merck Sharp & Dohme LLC | $15.55 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141849812 | CMS |
| PFIZER INC. | $113.59 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131522721 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.